Kurt Von Emster, Director at CymaBay Therapeutics, Inc. (CBAY), sold 4,300 shares at $10.21 ($44K) on 2018-01-05, disclosed to the SEC on 2018-01-09.
Scheduled sale ($44k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |